These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8667639)

  • 21. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
    Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
    Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor necrosis factor alpha and adiponectin in bone marrow interstitial fluid from patients with acute myeloid leukemia inhibit normal hematopoiesis.
    Iversen PO; Wiig H
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6793-9. PubMed ID: 16203766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
    Sarris AH; Talpaz M; Deisseroth AB; Estrov Z
    Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
    Betticher DC; Huxol H; Müller R; Speck B; Nissen C
    Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential manipulation of normal and chronic myeloid leukemia stem cell proliferation in vitro.
    Eaves C; Eaves A
    Blood Cells; 1994; 20(1):83-93; discussion 93-5. PubMed ID: 7994064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth kinetics and blast-colony forming cell binding capacity of stromal cells in various haematological malignancies.
    el-Khatib Y; Gidáli J; Fehér I; Mód A; Poros A; Hollán S
    Haematologia (Budap); 1991; 24(2):77-82. PubMed ID: 1816058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in the bone marrow microenvironment may elicit defective hematopoiesis: a comparison of aplastic anemia, chronic myeloid leukemia, and normal bone marrow.
    Park M; Park CJ; Cho YW; Jang S; Lee JH; Lee JH; Lee KH; Lee YH
    Exp Hematol; 2017 Jan; 45():56-63. PubMed ID: 27693387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation-inducing effect of recombinant human tumor necrosis factor alpha and gamma-interferon in vitro on blast cells from patients with acute myeloid leukemia and myeloid blast crisis of chronic myeloid leukemia.
    Geissler K; Tricot G; Leemhuis T; Walker E; Broxmeyer HE
    Cancer Res; 1989 Jun; 49(11):3057-62. PubMed ID: 2497971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization and selection of benign stem cells in chronic myeloid leukemia.
    Lemoli RM
    Haematologica; 1993; 78(6):393-400. PubMed ID: 8175034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematon: a multicellular functional unit in primary hematopoiesis.
    Blazsek I; Misset JL; Comisso M; Mathé G
    Biomed Pharmacother; 1988; 42(10):661-8. PubMed ID: 3266080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deficient proliferation and expansion in vitro of two bone marrow cell populations from patients with acute myeloid leukemia in response to hematopoietic cytokines.
    Montesinos JJ; Sánchez-Valle E; Flores-Figueroa E; Martínez-Jaramillo G; Flores-Guzmán P; Miranda-Peralta E; Gutiérrez-Romero M; Mayani H
    Leuk Lymphoma; 2006 Jul; 47(7):1379-86. PubMed ID: 16923572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Special Education: Aplastic Anemia.
    Teramura M; Mizoguchi H
    Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of evidence for abnormal autocrine or paracrine mechanisms underlying the uncontrolled proliferation of primitive chronic myeloid leukemia progenitor cells.
    Otsuka T; Eaves CJ; Humphries RK; Hogge DE; Eaves AC
    Leukemia; 1991 Oct; 5(10):861-8. PubMed ID: 1961020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Linkage of proliferative and maturational abnormalities in chronic myelogenous leukemia and relevance to treatment.
    Clarkson B; Strife A
    Leukemia; 1993 Nov; 7(11):1683-721. PubMed ID: 8231240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. c-abl function in normal and chronic myelogenous leukemia hematopoiesis: in vitro studies with antisense oligomers.
    Rosti V; Bergamaschi G; Ponchio L; Cazzola M
    Leukemia; 1992 Jan; 6(1):1-7. PubMed ID: 1736009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deficiency of a phosphatidylinositol-anchored cell adhesion molecule influences haemopoietic progenitor binding to marrow stroma in chronic myeloid leukaemia.
    Gordon MY; Atkinson J; Clarke D; Dowding CR; Goldman JM; Grimsley PG; Siczkowski M; Greaves MF
    Leukemia; 1991 Aug; 5(8):693-8. PubMed ID: 1715960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical utility of bone marrow culture.
    Moore MA
    Hamatol Bluttransfus; 1976; 19():79-90. PubMed ID: 795748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome.
    Flores-Figueroa E; Gutiérrez-Espíndola G; Montesinos JJ; Arana-Trejo RM; Mayani H
    Leuk Res; 2002 Jul; 26(7):677-86. PubMed ID: 12008086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stromal abnormalities in neoplastic bone marrow diseases.
    Dührsen U; Hossfeld DK
    Ann Hematol; 1996 Aug; 73(2):53-70. PubMed ID: 8774614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.